Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safety of an immunomodulator Mycobacterium w in COVID-19.

Literature DB >> 32367857

Safety of an immunomodulator Mycobacterium w in COVID-19.

Inderpaul Singh Sehgal¹, Ashish Bhalla², Goverdhan Dutt Puri³, Laxmi Narayana Yaddanapudi³, Mini Singh⁴, Pankaj Malhotra², Sahajal Dhooria¹, Vikas Suri², Ritesh Agarwal¹.

Abstract

Entities: Chemical Disease Gene Species

Year: 2020 PMID： 32367857 DOI： 10.4103/lungindia.lungindia_242_20

Source DB: PubMed Journal: Lung India ISSN： 0970-2113

× No keyword cloud information.

6 in total

1. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India.

Authors: Shiv Lal Soni; Kamal Kajal; L N Yaddanapudi; Pankaj Malhotra; Goverdhan Dutt Puri; Ashish Bhalla; Mini P Singh; Inderpaul Singh Sehgal; Vipin Koushal; Neelam Varma; Manisha Biswal; P V M Lakshmi; Sadhna Sharma; Vikas Suri; Z Deepy; Sant Ram; Jaivinder Yadav; Navin Pandey; Prashant Sharma; Nabhajit Malik; Kapil Goyal; Aseem Mehra; Swapnajeet Sahoo; Ritin Mohindra; Jijo Francis; Mudit Bhargava; Karan Singla; Preena Babu; Amiy Verma; Niranjan Shiwaji Khaire; R R Guru
Journal: Indian J Med Res Date: 2021 Jan & Feb Impact factor: 2.375

Safety of an immunomodulator Mycobacterium w in COVID-19.

1. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India.

Review 2. Emerging trends from COVID-19 research registered in the Clinical Trials Registry - India.

3. Injection site reactions associated with the use of Mycobacterium w in COVID-19 patients.

4. A randomised trial of Mycobacterium w in critically ill patients with COVID-19: ARMY-1.

5. Early Experience of High-dose Intravenous Mycobacterium w in Critically Ill Patients of COVID-19.

6. Cytokine Storm and Immunomodulation in COVID-19.